Search research articles
Contact Us
Filters
Showing results (51-60 of 65) with videos related to
Page
of 7
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
March 1, 2013
BCL2A1 is a lineage-specific antiapoptotic melanoma oncogene that confers resistance to BRAF inhibition
Rizwan Haq, Satoru Yokoyama, Elena B Hawryluk, et al.
Cancer
|
June 23, 2020
Vitamin D intake is associated with decreased risk of immune checkpoint inhibitor-induced colitis
Shilpa Grover, Michael Dougan, Kevin Tyan, et al.
Cancer Discovery
|
May 7, 2020
Inactivation of <i>Fbxw7</i> Impairs dsRNA Sensing and Confers Resistance to PD-1 Blockade
Cécile Gstalder, David Liu, Diana Miao, et al.
Biorxiv : the Preprint Server for Biology
|
February 20, 2025
Clinico-genomic features predict distinct metastatic phenotypes in cutaneous melanoma
Tyler J Aprati, Chi-Ping Day, Daniel Lee, et al.
Cancer Cell
|
June 10, 2025
Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma
Kevin Bi, Meng Xiao He, Ziad Bakouny, et al.
Cancer Cell
|
March 12, 2021
Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma
Kevin Bi, Meng Xiao He, Ziad Bakouny, et al.
Nature Genetics
|
August 29, 2018
Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumors
Diana Miao, Claire A Margolis, Natalie I Vokes, et al.
Cancer Discovery
|
May 1, 2024
A Next-Generation BRAF Inhibitor Overcomes Resistance to BRAF Inhibition in Patients with BRAF-Mutant Cancers Using Pharmacokinetics-Informed Dose Escalation
Rona Yaeger, Meredith A McKean, Rizwan Haq, et al.
Cell Reports
|
January 5, 2022
Integrative clinical and molecular characterization of translocation renal cell carcinoma
Ziad Bakouny, Ananthan Sadagopan, Praful Ravi, et al.
Science Advances
|
November 27, 2024
Genomic heterogeneity and ploidy identify patients with intrinsic resistance to PD-1 blockade in metastatic melanoma
Giuseppe Tarantino, Cora A Ricker, Annette Wang, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 65) with videos related to
Sort By:
Page
of 7
Proceedings of the National Academy of Sciences of the United States of America
|
March 1, 2013
BCL2A1 is a lineage-specific antiapoptotic melanoma oncogene that confers resistance to BRAF inhibition
Rizwan Haq, Satoru Yokoyama, Elena B Hawryluk, et al.
Cancer
|
June 23, 2020
Vitamin D intake is associated with decreased risk of immune checkpoint inhibitor-induced colitis
Shilpa Grover, Michael Dougan, Kevin Tyan, et al.
Cancer Discovery
|
May 7, 2020
Inactivation of <i>Fbxw7</i> Impairs dsRNA Sensing and Confers Resistance to PD-1 Blockade
Cécile Gstalder, David Liu, Diana Miao, et al.
Biorxiv : the Preprint Server for Biology
|
February 20, 2025
Clinico-genomic features predict distinct metastatic phenotypes in cutaneous melanoma
Tyler J Aprati, Chi-Ping Day, Daniel Lee, et al.
Cancer Cell
|
June 10, 2025
Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma
Kevin Bi, Meng Xiao He, Ziad Bakouny, et al.
Cancer Cell
|
March 12, 2021
Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma
Kevin Bi, Meng Xiao He, Ziad Bakouny, et al.
Nature Genetics
|
August 29, 2018
Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumors
Diana Miao, Claire A Margolis, Natalie I Vokes, et al.
Cancer Discovery
|
May 1, 2024
A Next-Generation BRAF Inhibitor Overcomes Resistance to BRAF Inhibition in Patients with BRAF-Mutant Cancers Using Pharmacokinetics-Informed Dose Escalation
Rona Yaeger, Meredith A McKean, Rizwan Haq, et al.
Cell Reports
|
January 5, 2022
Integrative clinical and molecular characterization of translocation renal cell carcinoma
Ziad Bakouny, Ananthan Sadagopan, Praful Ravi, et al.
Science Advances
|
November 27, 2024
Genomic heterogeneity and ploidy identify patients with intrinsic resistance to PD-1 blockade in metastatic melanoma
Giuseppe Tarantino, Cora A Ricker, Annette Wang, et al.
Page
of 7